An occasional cough helps clear irritants and secretions from your lungs and prevents infection. But if you develop a chronic cough that persists for weeks, you should find out if you have a medical ...

Sanofi reports amlitelimab improved lung function in asthma, with new phase 3 trials planned across its respiratory pipeline.

Sanofi’s respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPDNew phase 2 data for amlitelimab show ...

Chronic lower respiratory diseases, namely, asthma and chronic obstructive pulmonary disease , are the fifth-leading cause of ...

Patients in five states who have severe asthma and are covered by Blue Cross Blue Shield are facing a new obstacle to getting treatment. On Tuesday, BCBS began mandating that severe asthma patients ...

The long-term safety and efficacy of omalizumab, alongside promising phase 3 trial results that demonstrated the efficacy and ...

Researchers used UK Biobank data to identify 70 proteins with genetically predicted roles in asthma, offering insights into ...

Researchers investigate the impact of early-life ozone exposure on asthma and wheezing in children alone and in combination ...

A new CT-scan based risk score facilitates the identification of patients at risk of revision endoscopic sinus surgery due to chronic rhinosinusitis. “This allows for early prediction of disease ...

Sanofi today shared new progress from its mid- to late-stage respiratory pipeline, including preliminary phase 2 results for amlitelimab in adults with moderate-to-severe asthma.